Deal worth up to $1.3 billion brings AI-powered GPCR target discovery into Lilly’s obesity and cardiometabolic pipeline. 2.

Higher Post-operative Day 1 (POD1) pain scores were independently associated with increased 30-day infectious and ...

Medical cannabis has a high discontinuation rate among patients with chronic musculoskeletal pain, particularly in the first ...

First FDA-approved therapy for non-cystic fibrosis bronchiectasis; addresses a major unmet respiratory need. 2. Phase 3 data ...

In this retrospective cohort study, the proportion of chemotherapy episodes delivered by oncology subspecialists in the ...

Progression-free survival and overall survival were significantly greater in the combination therapy group compared to ...

Patients with severely disturbed sleep had the highest comorbidity burden, lowest ejection fraction, and poorest cognitive ...

Among children with acute lymphoblastic leukemia, overweight or obesity at >2 time points (longer duration) was associated ...

The Guselkumab group demonstrated significantly greater clinical and endoscopic responses versus placebo. 2. Serious adverse ...

In septic patients with liver cirrhosis, the neutrophil-to-lymphocyte (NLR) ratio was positively correlated with all-cause ...

A subset of patients undergoing cervical medial branch blocks experienced meaningful short- to medium-term pain and ...

In patients with Crohn’s disease (CD) of the pouch following ileal-pouch anal anastomosis (IPAA) for medically-refractory ...